These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 36092222)
1. Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India. Sil A; Jakhar D; Das A; Jagadeesan S; Aradhya SS Indian J Dermatol; 2022; 67(2):115-120. PubMed ID: 36092222 [TBL] [Abstract][Full Text] [Related]
2. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079 [TBL] [Abstract][Full Text] [Related]
5. Covid-19 Vaccines Available in India. Mukim M; Sharma P; Patweker M; Patweker F; Kukkar R; Patel R Comb Chem High Throughput Screen; 2022; 25(14):2391-2397. PubMed ID: 35293291 [TBL] [Abstract][Full Text] [Related]
6. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India. Chakraborty A; Reval N; Kamath L Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous reactions to COVID-19 vaccines: A review. Tan SW; Tam YC; Pang SM JAAD Int; 2022 Jun; 7():178-186. PubMed ID: 35194586 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous Adverse Drug Reactions (CADRs) to COVID19 Vaccines: A Case Series. Purushottam M; Rangappa V; Betkerur JB; Kombettu AP; Shastry V Indian Dermatol Online J; 2023; 14(3):383-387. PubMed ID: 37266107 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis. Contractor A; Shivaprakash S; Tiwari A; Setia MS; Gianchandani T PLoS One; 2022; 17(10):e0276759. PubMed ID: 36301977 [TBL] [Abstract][Full Text] [Related]
11. Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review. Bin Rubaian NF; Aljalfan AA; Almuhaidib SR J Family Community Med; 2023; 30(3):161-170. PubMed ID: 37675215 [TBL] [Abstract][Full Text] [Related]
12. A Study to Describe the Pattern of Cutaneous Adverse Effects of COVID-19 Vaccines (Covishield and Covaxin). Saraswat N; Tripathy DM; Murali M; Boruah J; Mitra D; Chopra H; Bhatnagar A Indian Dermatol Online J; 2023; 14(6):814-820. PubMed ID: 38099027 [TBL] [Abstract][Full Text] [Related]
13. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature. Buckley JE; Landis LN; Rapini RP JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review. Kroumpouzos G; Paroikaki ME; Yumeen S; Bhargava S; Mylonakis E Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336199 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal Follow-Up Study on the Side Effects of COVID-19 Vaccines: A Telephonic Questionnaire Approach. Priya Jakkula K; Kishore J; Maheswar Rao U Cureus; 2024 Jun; 16(6):e62917. PubMed ID: 39040783 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291 [TBL] [Abstract][Full Text] [Related]
18. Clinical observation and analysis of skin reactions caused by COVID-19 vaccination. Li Y; Fan L; Mao Q; Luan X; Wang Z; Zeng N; Cheng Y; Li Y; Xia Q; Lu Z; Lu Q; Min W; Luo D Dermatol Ther; 2022 Oct; 35(10):e15746. PubMed ID: 36190010 [TBL] [Abstract][Full Text] [Related]
19. Morbilliform Eruption After Administration of Second Dose of Oxford/AstraZeneca Vaccine. Alhammad NS; Milibary HH; Baghdadi RR; Alawadi TM; Hudairy RE Cureus; 2022 May; 14(5):e24649. PubMed ID: 35663693 [TBL] [Abstract][Full Text] [Related]
20. Assessment of safety and adverse drug reactions of COVID vaccination in the South Indian population: An observational prospective cross-sectional study. Manda A; Koya P; Pallem R; Mohd D; Thatikonda K; Venkateshwarlu K Ann Med Surg (Lond); 2022 Dec; 84():104948. PubMed ID: 36536701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]